These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. de Groot MJ, Vermeulen NP, Kramer JD, van Acker FA, Donné-Op den Kelder GM. Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262 [Abstract] [Full Text] [Related]
3. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase. Modi S, Gilham DE, Sutcliffe MJ, Lian LY, Primrose WU, Wolf CR, Roberts GC. Biochemistry; 1997 Apr 15; 36(15):4461-70. PubMed ID: 9109653 [Abstract] [Full Text] [Related]
7. A refined substrate model for human cytochrome P450 2D6. de Groot MJ, Bijloo GJ, Martens BJ, van Acker FA, Vermeulen NP. Chem Res Toxicol; 1997 Jan 15; 10(1):41-8. PubMed ID: 9074801 [Abstract] [Full Text] [Related]
12. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. Oliver CF, Modi S, Sutcliffe MJ, Primrose WU, Lian LY, Roberts GC. Biochemistry; 1997 Feb 18; 36(7):1567-72. PubMed ID: 9048540 [Abstract] [Full Text] [Related]
14. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Roitel O, Scrutton NS, Munro AW. Biochemistry; 2003 Sep 16; 42(36):10809-21. PubMed ID: 12962506 [Abstract] [Full Text] [Related]
17. A natural variant of the heme-binding signature (R441C) resulting in complete loss of function of CYP2D6. Klein K, Tatzel S, Raimundo S, Saussele T, Hustert E, Pleiss J, Eichelbaum M, Zanger UM. Drug Metab Dispos; 2007 Aug 16; 35(8):1247-50. PubMed ID: 17460029 [Abstract] [Full Text] [Related]